pharmatechoutlook
4MAY 2024TECH OUTLOOKIN MY OPINIONFrom Complex to Compliance: 3 Keys for Unlocking the Regulatory PathwayNicholas Smalley,Vice President of Regulatory Affairs,Kindeva Drug Delivery08LAST WORD30How a Quality Improvement Plan Can Enhance Quality MaturityJennifer Vavala,Senior Director Quality Assurance,Ajinomoto Bio-Pharma Services12COVER STORYCHEMOGENICS BIOPHARMAEXCELLENCE IN COLLABORATIVE RESEARCH RESULTING IN COMMERCIAL AND CLINICAL COMPOUNDSFRANCIS TAVARES, PRESIDENT AND CEO
< Page 3 | Page 5 >